Internal Medicine, Endocrinology, Diabetes, & Metabolism · Opelika, AL
NPI
1992847669
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
3320 Skyway Dr, Suite 808
Opelika, AL, 36801
Phone (334) 737-2737
Groups this clinician bills Medicare through
Medicare paid, 2024
$288K
20,723 services
Medicare patients, 2024
747
Average age 71
Drug cost, 2024
$3.8M
4,975 prescriptions
Company payments, 2025
$98K
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bantwal S Baliga was code J1071 (injection, testosterone cypionate, 1 mg), 15,150 times for 12 patients. In total Bantwal S Baliga billed 20,723 services in 43 codes, and Medicare paid $288K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 15,150 | 12 | $0.02 | $357 |
| 99454 E&M - Miscellaneous | Office | 1,219 | 208 | $31.46 | $38K |
| 99457 E&M - Miscellaneous | Office | 1,178 | 212 | $34.44 | $41K |
| 99214 Office E&M - Established | Office | 748 | 410 | $88.08 | $66K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 619 | 194 | $42.36 | $26K |
| 99213 Office E&M - Established | Office | 389 | 282 | $59.93 | $23K |
| 95251 Test - Miscellaneous | Office | 295 | 158 | $24.37 | $7,190 |
| 82962 Clinical Chemistry | Office | 223 | 165 | $3.14 | $701 |
| 99458 E&M - Miscellaneous | Office | 202 | 50 | $28.79 | $5,816 |
| 99204 Office E&M - New | Office | 112 | 112 | $110.60 | $12K |
| 83036 Blood Count | Office | 108 | 98 | $9.52 | $1,028 |
| 99453 E&M - Miscellaneous | Office | 94 | 93 | $13.77 | $1,294 |
| 76536 Ultrasound - Nonspecific | Office | 89 | 87 | $70.89 | $6,309 |
| 96372 Injection Administration | Office | 74 | 16 | $10.13 | $749 |
| 76981 Ultrasound - Nonspecific | Office | 60 | 59 | $71.64 | $4,298 |
By year: 2022 $299K for 11,836 services; 2023 $287K for 11,103 services; 2024 $288K for 20,723 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 223 | 165 | $3.14 | $701 |
| 83036 Blood Count | 108 | 98 | $9.52 | $1,028 |
Medicare prescription drug claims, 2024
In 2024, the drug Bantwal S Baliga prescribed most often to Medicare patients was Ozempic (Semaglutide), with 545 prescriptions and refills. In total Bantwal S Baliga wrote 4,975 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 545 | 708 | 188 | $637K |
| Levothyroxine Sodium Generic | 376 | 896 | 174 | $4,238 |
| Jardiance Empagliflozin | 260 | 406 | 91 | $240K |
| Mounjaro Tirzepatide | 224 | 265 | 77 | $283K |
| Farxiga Dapagliflozin Propanediol | 166 | 296 | 74 | $164K |
| Metformin Hcl Er Metformin Hcl | 151 | 290 | 76 | $1,543 |
| Novolog Insulin Aspart | 121 | 167 | 61 | $37K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 120 | 248 | 62 | $15K |
| Tresiba Flextouch U-100 Insulin Degludec | 118 | 265 | 60 | $71K |
| V-Go 30 Sub-Q Insulin Device, 30 Unit | 111 | 149 | 50 | $75K |
| Metformin Hcl Generic | 108 | 282 | 57 | $893 |
| Humalog Kwikpen U-100 Insulin Lispro | 101 | 170 | 48 | $28K |
| V-Go 40 Sub-Q Insulin Device, 40 Unit | 100 | 130 | 39 | $67K |
| Humalog Insulin Lispro | 100 | 143 | 40 | $24K |
| Liothyronine Sodium Generic | 94 | 208 | 46 | $5,573 |
Brand drugs: 3,049 claims; generic drugs: 1,469 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bantwal S Baliga $98K ($98K in general payments such as food, travel and fees) from 30 companies. The largest payer was Lilly USA, LLC with $48K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 57 | $48K |
| Abbott Laboratories ABT | 83 | $43K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $1,644 |
| Beta Bionics, Inc. BBNX | 15 | $1,051 |
| Novo Nordisk Inc NVO | 25 | $698 |
| Medtronic, Inc. MDT | 9 | $449 |
| Xeris Pharmaceuticals, Inc. | 9 | $403 |
| Sequel Med Tech, LLC | 4 | $208 |
| Ascendis Pharma Endocrinology Inc ASND | 6 | $206 |
| CeQur Corporation | 1 | $186 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.